New Delhi, October 27 (IANS): A community-based Ayurveda intervention conducted by the All India Institute of Ayurveda (AIIA) in Haryana's Faridabad recorded improvements in quality of life, Agnibala and bone m
New Delhi, October 25 (IANS) Artificial intelligence (AI) could play a transformative role in India's fight against tuberculosis (TB) and lung cancer by supporting earlier detection, faster diagnosis and more e
Mohali, October 24 (IANS): The quality and quantity of information related to childhood cancer survival rate in the country is likely to get better over the next five years due to the big strides taken during t
New Delhi, October 23 (IANS) The Centre has told the Supreme Court that capping trade margins on anti-cancer medicines at 30 per cent of their maximum retail price (MRP) is expected to save patients around Rs 2
New Delhi, October 18 (IANS) The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on 137 non-scheduled anti-cancer drugs at 30 per cent of the maximum retail price (MRP), a move expecte
New Delhi, October 17 (IANS) India will need an additional 2.6 billion sq. ft. of healthcare real estate by 2035, as the country needs nearly 2.9 million incremental hospital beds to align with global healthcar
New Delhi, October 14 (IANS): The National Institute of Pharmaceutical Education and Research (NIPER), Raebareli and AstraZeneca India have collaborated to expand clinical trial capabilities beyond metros to st
New Delhi, October 13 (IANS): The Ministry of Ayush on Tuesday released Standard Treatment Guidelines (STGs) on the management of dermatological disorders across Ayurveda, Siddha, Unani and Homoeopathy systems,
New Delhi, October 9 (IANS): The Union Ministry of Health and Family Welfare on Friday proposed stricter regulations governing the advertisement of prescription medicines, seeking to extend existing restriction
New Delhi, October 8 (IANS) The Food Safety and Standards Authority of India (FSSAI) on Thursday said that it has issued notices to Dr Reddys, Nestle Health Science, Tirupati Wellness, Amazon, Flipkart and Netm
New Delhi, October 8 (IANS) In a major step aimed at making cancer treatment more affordable, the government has reportedly decided to cap trade margins at 30 per cent of the maximum retail price (MRP) for all
New Delhi, October 6 (IANS): Cervavac -- India's first indigenously developed human papillomavirus (HPV) vaccine -- has received prequalification from the World Health Organization (WHO) which makes it eligible
New Delhi, October 2 (IANS) Union Minister of State (Independent Charge) for Science and Technology and Earth Sciences, Dr. Jitendra Singh, on Friday said robotics is poised to become a key enabler across every
New Delhi, September 28 (IANS) A large multicentre clinical study published in Frontiers in Medicine found daily administration of a standardised Ashwagandha root extract for 24 weeks was well tolerated with no
New Delhi, September 26 (IANS): At a UN high‑level meeting on pandemic prevention and response in New York, Health Secretary Punya Salila Srivastava has called for fair Pathogen Access and Benefit Sharing (PA
New Delhi, September 24 (IANS) Indias food regulator has proposed to prohibit manufacturing and sale of analogue paneer across the country, notifying draft amendments for consultations.According to the FSSAI dr
New Delhi, September 22 (IANS): The Centre has released Rs 6,406.99 crore through the National Ayush Mission (NAM) to States and Union Territories between financial years 2014–15 and 2025–26 to expand and i
New Delhi, September 21 (IANS) The Central government on Monday launched the 7th Edition of the National Formulary of India (NFI) and the ADR-PvPI 2.0 Mobile App for iOS users at the 6th National Pharmacovigila
New Delhi, September 19 (IANS): Ayush Ministry is now advancing artificial intelligence (AI) as the next frontier for Ayurveda and the wider Ayush sector, it said on Saturday.The ministry said it has been explo
New Delhi, September 17 (IANS): The government on Thursday said it has proposed amendments to strengthen regulatory oversight over Schedule H, H1 and X drugs, along with recommending mandatory CCTV surveillance